SAN FRANCISCO, July 31, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare ...

All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

A Springfield attorney was fined for citing fabricated cases created by AI in legal briefs. The attorney, William Panichi, admitted to using AI due to a heavy workload at the time. This case marks ...

Lyricist Tim Rice said he has not yet used AI to help write music but is not opposed to it Lyricist Tim Rice has said he would "consider" using artificial intelligence (AI) to help write songs.

Using China's Five-hundred-meter Aperture Spherical Radio Telescope (FAST), researchers have uncovered new magnetic field structures in a rare class of binary star systems known as spider pulsars ...

The rise of AI tools that write about you when you die Families and funeral directors are using AI obituary generators to more efficiently memorialize the dead. What happens when they get it wrong?

ECLIPSE 2 is one of three trials in Vir Biotechnology’s registrational ECLIPSE program for CHD, which was initiated in March 2025.

Climb and Jump Tower recently started the Angels vs Demons event, a competitive event where players participate to earn the most Wins for their teams.

A New York-based start-up company wants to use batteries to reduce stress on the energy grid and put money back in the pockets of state residents.

The ChatGPT chatbot by OpenAI has taken the world by storm. Here's how to use it and everything you need to know about AI text generation with GPT.

Reuters.com is your online source for the latest world news stories and current events, ensuring our readers up to date with any breaking news developments ...